Sector Specific Report (Health Sector) l January 2022

Please wait while flipbook is loading. For more related info, FAQs and issues please refer to DearFlip WordPress Flipbook Plugin Help documentation.

India in January 2022 witnessed the much-awaited market authorization of two indigenous Covid-19 vaccines Covishield and Covaxin by the Drugs Controller of India (DCGI) subject to certain conditions mentioned by the authorities. This means the vaccines will be used as a permitted drug for the adult population concerning certain conditions w.e.f. 19th January 2022. Till now, these vaccines were only available for restricted use in case of emergencies.